Looking to publish in Clinical And Molecular Hepatology? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.
Try Livewrite NowClinical and Molecular Hepatology is an international, peer-reviewed, open-access journal published quarterly in English. It focuses on advanced knowledge, trends, and understanding of hepatobiliary diseases, aims to support debate among clinical doctors, translational researchers, and basic scientists, and emphasizes public health through a multidisciplinary approach, especially in resource-limited Asia-Pacific regions with high prevalence of hepatitis B viral infection and hepatocellular carcinoma. The journal gives priority to epidemiological studies of hepatobiliary diseases across Asia, Africa, parts of Europe, and the Americas, and publishes original papers, meta-analyses, letters to the editor, case reports, reviews, guidelines, editorials, and liver image and pathology articles in hepatology.
Looking to publish in Clinical And Molecular Hepatology? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.
Try Livewrite NowSubmission Instructions
Clinical And Molecular Hepatology accepts the following article types. Click on an article type to view submission instructions.
Original Articles
Review Articles
Letters To The Editor
Research Letter
Guidelines
Editorials
Recent Publications
Systemic Metabolic Dysfunction Drives Platelet-Mediated Inflammation, Fibrogenesis, and Hepatocarcinogenesis in MASLD
Bingjie Ye, Chengfu Xu
Cardiovascular and Hepatic Outcomes: Prognostic Differences Across MASLD-MetALD-ALD Continuum
Han Ah Lee, Gi-Ae Kim, Won Kim
KASL clinical practice guidelines for liver cirrhosis: Ascites and related complications 2026
Do Seon Song, Jeong-Ju Yoo, Jeong Eun Song, Seong Hee Kang, Seung Kak Shin, Seul Ki Han, Sung Won Chung, Ki-Ae Kim, Moon Haeng Hur, Han Ah Lee, Yeonjung Ha, Young Chang, Jae Hyun Yoon, Jae Seung Lee, Sang Gyune Kim, Young Kul Jung, Moon Young Kim
Predictive modeling and clinical decision tools for risk stratification in steatotic liver disease
Jeanette Girard, Elliot B. Tapper, Vincent L. Chen
Lack of Association Between Rifaximin and Drug-resistant Infections: A global multicenter inpatient cirrhosis cohort
Jasmohan S Bajaj, Patrick S Kamath, Florence Wong, Qing Xie, Ramazan Idilman, Mark Topazian, Wai-Kay Seto, Aldo Torre, Peter Hayes, Jacob George, Mario Alvares da Silva, Brian J Bush, Scott Silvey, Ashok Choudhury
Frequently asked questions
How long does it take to publish?
Decisions are available in approximately one month. Fast-track review provides a first decision within 7 days of submission and accepted papers are published within 2 weeks from acceptance.
Reformat to Clinical And Molecular Hepatology using Livewrite PremiumWhat are the publication costs?
Free online access to all published and ahead-of-print articles. Print subscription is free for official members of the Korean Association for the Study of the Liver, and non-members are charged an annual subscription fee.
Reformat to Clinical And Molecular Hepatology using Livewrite Premium